ERBB2 and breast carcinoma: (61) developed the iREX (Integrated Raman Spectroscopy EXO) biosensor, which is capable of multiple quantitatively analyzing proteins of exosomes (MUC1, HER2 and CEA) in clinical plasma samples from breast cancer patients (Figure 1).